nivolumab
bms
['oval', 'nivo', 'nivolumab', 'rova', 'mibc']
the current landscape of adjuvant therapy in mibc - dfs benefit led to fda approval of adjuvant nivolumab, no os benefit yet
&amp; table of ongoing phase 3 trials in this space by #guonc #asco22 
GU Oncology Fellow | NOLA Heme/Onc Alumni | Interested in GU, Immuno Onc & Med Ed | #ASCO22 Featured Voice | COI: https://t.co/X1Y9QuHs6L